Psammaplin A is a marine metabolite with potent inhibitory activity against histone deacetylases (HDACs) and DNA methyltransferases; it exhibits selective inhibition of HDAC1 (IC50 = 0.9 nM), showing 360-fold selectivity over HDAC6 and over 1000-fold lower potency against HDAC7 and HDAC8; it possesses antibacterial activity against Gram-positive bacteria by inhibiting DNA synthesis and DNA gyrase activity; it demonstrates antitumor activity.